nodes	percent_of_prediction	percent_of_DWPC	metapath
Rimantadine—Amantadine—ABCB1—peripheral nervous system neoplasm	0.0152	1	CrCbGaD
Rimantadine—Dyspepsia—Melphalan—peripheral nervous system neoplasm	0.00254	0.00258	CcSEcCtD
Rimantadine—Gastrointestinal disorder—Tretinoin—peripheral nervous system neoplasm	0.00253	0.00256	CcSEcCtD
Rimantadine—Gastrointestinal disorder—Isotretinoin—peripheral nervous system neoplasm	0.00253	0.00256	CcSEcCtD
Rimantadine—Fatigue—Tretinoin—peripheral nervous system neoplasm	0.00252	0.00256	CcSEcCtD
Rimantadine—Fatigue—Isotretinoin—peripheral nervous system neoplasm	0.00252	0.00256	CcSEcCtD
Rimantadine—Constipation—Topotecan—peripheral nervous system neoplasm	0.00252	0.00256	CcSEcCtD
Rimantadine—Decreased appetite—Melphalan—peripheral nervous system neoplasm	0.00251	0.00255	CcSEcCtD
Rimantadine—Constipation—Tretinoin—peripheral nervous system neoplasm	0.0025	0.00254	CcSEcCtD
Rimantadine—Constipation—Isotretinoin—peripheral nervous system neoplasm	0.0025	0.00254	CcSEcCtD
Rimantadine—Agitation—Alitretinoin—peripheral nervous system neoplasm	0.0025	0.00253	CcSEcCtD
Rimantadine—Gastrointestinal disorder—Melphalan—peripheral nervous system neoplasm	0.00249	0.00253	CcSEcCtD
Rimantadine—Fatigue—Melphalan—peripheral nervous system neoplasm	0.00249	0.00253	CcSEcCtD
Rimantadine—Tinnitus—Cisplatin—peripheral nervous system neoplasm	0.00248	0.00252	CcSEcCtD
Rimantadine—Syncope—Alitretinoin—peripheral nervous system neoplasm	0.00244	0.00247	CcSEcCtD
Rimantadine—Feeling abnormal—Topotecan—peripheral nervous system neoplasm	0.00243	0.00247	CcSEcCtD
Rimantadine—Hypoaesthesia—Etoposide—peripheral nervous system neoplasm	0.00242	0.00246	CcSEcCtD
Rimantadine—Gastrointestinal pain—Topotecan—peripheral nervous system neoplasm	0.00241	0.00245	CcSEcCtD
Rimantadine—Feeling abnormal—Tretinoin—peripheral nervous system neoplasm	0.00241	0.00245	CcSEcCtD
Rimantadine—Feeling abnormal—Isotretinoin—peripheral nervous system neoplasm	0.00241	0.00245	CcSEcCtD
Rimantadine—Agitation—Vincristine—peripheral nervous system neoplasm	0.00241	0.00244	CcSEcCtD
Rimantadine—Palpitations—Alitretinoin—peripheral nervous system neoplasm	0.0024	0.00244	CcSEcCtD
Rimantadine—Gastrointestinal pain—Tretinoin—peripheral nervous system neoplasm	0.00239	0.00243	CcSEcCtD
Rimantadine—Gastrointestinal pain—Isotretinoin—peripheral nervous system neoplasm	0.00239	0.00243	CcSEcCtD
Rimantadine—Loss of consciousness—Alitretinoin—peripheral nervous system neoplasm	0.00239	0.00242	CcSEcCtD
Rimantadine—Cough—Alitretinoin—peripheral nervous system neoplasm	0.00237	0.00241	CcSEcCtD
Rimantadine—Mental disability—Epirubicin—peripheral nervous system neoplasm	0.00236	0.0024	CcSEcCtD
Rimantadine—Convulsion—Alitretinoin—peripheral nervous system neoplasm	0.00235	0.00239	CcSEcCtD
Rimantadine—Hypertension—Alitretinoin—peripheral nervous system neoplasm	0.00235	0.00238	CcSEcCtD
Rimantadine—Abdominal pain—Topotecan—peripheral nervous system neoplasm	0.00233	0.00237	CcSEcCtD
Rimantadine—Abdominal pain—Isotretinoin—peripheral nervous system neoplasm	0.00231	0.00235	CcSEcCtD
Rimantadine—Abdominal pain—Tretinoin—peripheral nervous system neoplasm	0.00231	0.00235	CcSEcCtD
Rimantadine—Anxiety—Alitretinoin—peripheral nervous system neoplasm	0.0023	0.00234	CcSEcCtD
Rimantadine—Anorexia—Dactinomycin—peripheral nervous system neoplasm	0.00228	0.00231	CcSEcCtD
Rimantadine—Convulsion—Vincristine—peripheral nervous system neoplasm	0.00227	0.0023	CcSEcCtD
Rimantadine—Dry mouth—Alitretinoin—peripheral nervous system neoplasm	0.00226	0.0023	CcSEcCtD
Rimantadine—Hypertension—Vincristine—peripheral nervous system neoplasm	0.00226	0.00229	CcSEcCtD
Rimantadine—Confusional state—Alitretinoin—peripheral nervous system neoplasm	0.00224	0.00227	CcSEcCtD
Rimantadine—Eye pain—Epirubicin—peripheral nervous system neoplasm	0.00219	0.00222	CcSEcCtD
Rimantadine—Chills—Etoposide—peripheral nervous system neoplasm	0.00219	0.00222	CcSEcCtD
Rimantadine—Mental disability—Doxorubicin—peripheral nervous system neoplasm	0.00218	0.00222	CcSEcCtD
Rimantadine—Shock—Alitretinoin—peripheral nervous system neoplasm	0.00218	0.00221	CcSEcCtD
Rimantadine—Tremor—Cisplatin—peripheral nervous system neoplasm	0.00217	0.0022	CcSEcCtD
Rimantadine—Tachycardia—Alitretinoin—peripheral nervous system neoplasm	0.00216	0.0022	CcSEcCtD
Rimantadine—Hyperhidrosis—Alitretinoin—peripheral nervous system neoplasm	0.00214	0.00218	CcSEcCtD
Rimantadine—Asthenia—Topotecan—peripheral nervous system neoplasm	0.00212	0.00215	CcSEcCtD
Rimantadine—Anorexia—Alitretinoin—peripheral nervous system neoplasm	0.00211	0.00215	CcSEcCtD
Rimantadine—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.0021	0.00213	CcSEcCtD
Rimantadine—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.0021	0.00213	CcSEcCtD
Rimantadine—Decreased appetite—Dactinomycin—peripheral nervous system neoplasm	0.00208	0.00211	CcSEcCtD
Rimantadine—Asthenia—Melphalan—peripheral nervous system neoplasm	0.00207	0.0021	CcSEcCtD
Rimantadine—Hyperhidrosis—Vincristine—peripheral nervous system neoplasm	0.00207	0.0021	CcSEcCtD
Rimantadine—Fatigue—Dactinomycin—peripheral nervous system neoplasm	0.00206	0.00209	CcSEcCtD
Rimantadine—Anorexia—Vincristine—peripheral nervous system neoplasm	0.00204	0.00207	CcSEcCtD
Rimantadine—Eye pain—Doxorubicin—peripheral nervous system neoplasm	0.00202	0.00205	CcSEcCtD
Rimantadine—Cardiac failure—Epirubicin—peripheral nervous system neoplasm	0.00202	0.00205	CcSEcCtD
Rimantadine—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.00202	0.00205	CcSEcCtD
Rimantadine—Convulsion—Cisplatin—peripheral nervous system neoplasm	0.00201	0.00204	CcSEcCtD
Rimantadine—Insomnia—Alitretinoin—peripheral nervous system neoplasm	0.00201	0.00204	CcSEcCtD
Rimantadine—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.002	0.00203	CcSEcCtD
Rimantadine—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.002	0.00203	CcSEcCtD
Rimantadine—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.00198	0.00201	CcSEcCtD
Rimantadine—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.00198	0.00201	CcSEcCtD
Rimantadine—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.00197	0.002	CcSEcCtD
Rimantadine—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.00197	0.002	CcSEcCtD
Rimantadine—Anxiety—Cisplatin—peripheral nervous system neoplasm	0.00196	0.00199	CcSEcCtD
Rimantadine—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.00196	0.00199	CcSEcCtD
Rimantadine—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.00195	0.00198	CcSEcCtD
Rimantadine—Dizziness—Topotecan—peripheral nervous system neoplasm	0.00195	0.00198	CcSEcCtD
Rimantadine—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.00193	0.00196	CcSEcCtD
Rimantadine—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.00193	0.00196	CcSEcCtD
Rimantadine—Insomnia—Vincristine—peripheral nervous system neoplasm	0.00193	0.00196	CcSEcCtD
Rimantadine—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.00193	0.00196	CcSEcCtD
Rimantadine—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.00191	0.00194	CcSEcCtD
Rimantadine—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.00191	0.00194	CcSEcCtD
Rimantadine—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.0019	0.00193	CcSEcCtD
Rimantadine—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.00189	0.00192	CcSEcCtD
Rimantadine—Vomiting—Topotecan—peripheral nervous system neoplasm	0.00187	0.0019	CcSEcCtD
Rimantadine—Cardiac failure—Doxorubicin—peripheral nervous system neoplasm	0.00187	0.0019	CcSEcCtD
Rimantadine—Loss of consciousness—Etoposide—peripheral nervous system neoplasm	0.00186	0.00189	CcSEcCtD
Rimantadine—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.00186	0.00189	CcSEcCtD
Rimantadine—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.00186	0.00189	CcSEcCtD
Rimantadine—Rash—Topotecan—peripheral nervous system neoplasm	0.00186	0.00189	CcSEcCtD
Rimantadine—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.00186	0.00189	CcSEcCtD
Rimantadine—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.00186	0.00189	CcSEcCtD
Rimantadine—Ataxia—Epirubicin—peripheral nervous system neoplasm	0.00186	0.00188	CcSEcCtD
Rimantadine—Cough—Etoposide—peripheral nervous system neoplasm	0.00185	0.00188	CcSEcCtD
Rimantadine—Headache—Topotecan—peripheral nervous system neoplasm	0.00185	0.00188	CcSEcCtD
Rimantadine—Rash—Isotretinoin—peripheral nervous system neoplasm	0.00184	0.00187	CcSEcCtD
Rimantadine—Rash—Tretinoin—peripheral nervous system neoplasm	0.00184	0.00187	CcSEcCtD
Rimantadine—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.00184	0.00187	CcSEcCtD
Rimantadine—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.00184	0.00187	CcSEcCtD
Rimantadine—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.00184	0.00187	CcSEcCtD
Rimantadine—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.00184	0.00187	CcSEcCtD
Rimantadine—Fatigue—Vincristine—peripheral nervous system neoplasm	0.00184	0.00187	CcSEcCtD
Rimantadine—Convulsion—Etoposide—peripheral nervous system neoplasm	0.00184	0.00187	CcSEcCtD
Rimantadine—Vomiting—Melphalan—peripheral nervous system neoplasm	0.00184	0.00186	CcSEcCtD
Rimantadine—Headache—Tretinoin—peripheral nervous system neoplasm	0.00183	0.00186	CcSEcCtD
Rimantadine—Headache—Isotretinoin—peripheral nervous system neoplasm	0.00183	0.00186	CcSEcCtD
Rimantadine—Hypertension—Etoposide—peripheral nervous system neoplasm	0.00183	0.00186	CcSEcCtD
Rimantadine—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.00183	0.00186	CcSEcCtD
Rimantadine—Constipation—Vincristine—peripheral nervous system neoplasm	0.00183	0.00185	CcSEcCtD
Rimantadine—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.00183	0.00185	CcSEcCtD
Rimantadine—Rash—Melphalan—peripheral nervous system neoplasm	0.00182	0.00185	CcSEcCtD
Rimantadine—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.00182	0.00185	CcSEcCtD
Rimantadine—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.00181	0.00184	CcSEcCtD
Rimantadine—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.0018	0.00183	CcSEcCtD
Rimantadine—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.00175	0.00178	CcSEcCtD
Rimantadine—Nausea—Topotecan—peripheral nervous system neoplasm	0.00175	0.00178	CcSEcCtD
Rimantadine—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.00175	0.00177	CcSEcCtD
Rimantadine—Confusional state—Etoposide—peripheral nervous system neoplasm	0.00174	0.00177	CcSEcCtD
Rimantadine—Nausea—Tretinoin—peripheral nervous system neoplasm	0.00174	0.00176	CcSEcCtD
Rimantadine—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.00174	0.00176	CcSEcCtD
Rimantadine—Ataxia—Doxorubicin—peripheral nervous system neoplasm	0.00172	0.00174	CcSEcCtD
Rimantadine—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.00172	0.00174	CcSEcCtD
Rimantadine—Nausea—Melphalan—peripheral nervous system neoplasm	0.00172	0.00174	CcSEcCtD
Rimantadine—Dysphagia—Epirubicin—peripheral nervous system neoplasm	0.00171	0.00173	CcSEcCtD
Rimantadine—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.00169	0.00171	CcSEcCtD
Rimantadine—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.00169	0.00171	CcSEcCtD
Rimantadine—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.00168	0.00171	CcSEcCtD
Rimantadine—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.00167	0.0017	CcSEcCtD
Rimantadine—Anorexia—Etoposide—peripheral nervous system neoplasm	0.00165	0.00167	CcSEcCtD
Rimantadine—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.00164	0.00167	CcSEcCtD
Rimantadine—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.00164	0.00166	CcSEcCtD
Rimantadine—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.00163	0.00166	CcSEcCtD
Rimantadine—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.00159	0.00162	CcSEcCtD
Rimantadine—Dysphagia—Doxorubicin—peripheral nervous system neoplasm	0.00158	0.0016	CcSEcCtD
Rimantadine—Pollakiuria—Epirubicin—peripheral nervous system neoplasm	0.00158	0.0016	CcSEcCtD
Rimantadine—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.00156	0.00158	CcSEcCtD
Rimantadine—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.00154	0.00157	CcSEcCtD
Rimantadine—Somnolence—Etoposide—peripheral nervous system neoplasm	0.00154	0.00156	CcSEcCtD
Rimantadine—Asthenia—Vincristine—peripheral nervous system neoplasm	0.00153	0.00156	CcSEcCtD
Rimantadine—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.00152	0.00154	CcSEcCtD
Rimantadine—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.00152	0.00154	CcSEcCtD
Rimantadine—Rash—Dactinomycin—peripheral nervous system neoplasm	0.00151	0.00153	CcSEcCtD
Rimantadine—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.0015	0.00153	CcSEcCtD
Rimantadine—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.00149	0.00152	CcSEcCtD
Rimantadine—Fatigue—Etoposide—peripheral nervous system neoplasm	0.00149	0.00151	CcSEcCtD
Rimantadine—Stomatitis—Epirubicin—peripheral nervous system neoplasm	0.00148	0.00151	CcSEcCtD
Rimantadine—Constipation—Etoposide—peripheral nervous system neoplasm	0.00148	0.0015	CcSEcCtD
Rimantadine—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.00147	0.00149	CcSEcCtD
Rimantadine—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.00146	0.00148	CcSEcCtD
Rimantadine—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	0.00146	0.00148	CcSEcCtD
Rimantadine—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.00143	0.00145	CcSEcCtD
Rimantadine—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.00142	0.00144	CcSEcCtD
Rimantadine—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.00142	0.00144	CcSEcCtD
Rimantadine—Dizziness—Vincristine—peripheral nervous system neoplasm	0.00141	0.00143	CcSEcCtD
Rimantadine—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.00141	0.00143	CcSEcCtD
Rimantadine—Rash—Alitretinoin—peripheral nervous system neoplasm	0.0014	0.00142	CcSEcCtD
Rimantadine—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.0014	0.00142	CcSEcCtD
Rimantadine—Headache—Alitretinoin—peripheral nervous system neoplasm	0.00139	0.00141	CcSEcCtD
Rimantadine—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	0.00137	0.00139	CcSEcCtD
Rimantadine—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.00137	0.00139	CcSEcCtD
Rimantadine—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.00136	0.00138	CcSEcCtD
Rimantadine—Vomiting—Vincristine—peripheral nervous system neoplasm	0.00136	0.00138	CcSEcCtD
Rimantadine—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.00136	0.00138	CcSEcCtD
Rimantadine—Rash—Vincristine—peripheral nervous system neoplasm	0.00135	0.00137	CcSEcCtD
Rimantadine—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.00135	0.00137	CcSEcCtD
Rimantadine—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.00135	0.00137	CcSEcCtD
Rimantadine—Headache—Vincristine—peripheral nervous system neoplasm	0.00134	0.00136	CcSEcCtD
Rimantadine—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.00132	0.00134	CcSEcCtD
Rimantadine—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.00129	0.00131	CcSEcCtD
Rimantadine—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.00127	0.00129	CcSEcCtD
Rimantadine—Nausea—Vincristine—peripheral nervous system neoplasm	0.00127	0.00129	CcSEcCtD
Rimantadine—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.00126	0.00128	CcSEcCtD
Rimantadine—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	0.00124	0.00126	CcSEcCtD
Rimantadine—Asthenia—Etoposide—peripheral nervous system neoplasm	0.00124	0.00126	CcSEcCtD
Rimantadine—Chills—Epirubicin—peripheral nervous system neoplasm	0.00123	0.00124	CcSEcCtD
Rimantadine—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.0012	0.00122	CcSEcCtD
Rimantadine—Rash—Cisplatin—peripheral nervous system neoplasm	0.00119	0.00121	CcSEcCtD
Rimantadine—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.00119	0.00121	CcSEcCtD
Rimantadine—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.00118	0.0012	CcSEcCtD
Rimantadine—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.00118	0.0012	CcSEcCtD
Rimantadine—Tension—Epirubicin—peripheral nervous system neoplasm	0.00117	0.00118	CcSEcCtD
Rimantadine—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.00115	0.00117	CcSEcCtD
Rimantadine—Dizziness—Etoposide—peripheral nervous system neoplasm	0.00114	0.00116	CcSEcCtD
Rimantadine—Chills—Doxorubicin—peripheral nervous system neoplasm	0.00113	0.00115	CcSEcCtD
Rimantadine—Nausea—Cisplatin—peripheral nervous system neoplasm	0.00112	0.00114	CcSEcCtD
Rimantadine—Vomiting—Etoposide—peripheral nervous system neoplasm	0.0011	0.00112	CcSEcCtD
Rimantadine—Agitation—Epirubicin—peripheral nervous system neoplasm	0.00109	0.00111	CcSEcCtD
Rimantadine—Rash—Etoposide—peripheral nervous system neoplasm	0.00109	0.00111	CcSEcCtD
Rimantadine—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.00109	0.00111	CcSEcCtD
Rimantadine—Headache—Etoposide—peripheral nervous system neoplasm	0.00108	0.0011	CcSEcCtD
Rimantadine—Tension—Doxorubicin—peripheral nervous system neoplasm	0.00108	0.0011	CcSEcCtD
Rimantadine—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.00107	0.00108	CcSEcCtD
Rimantadine—Syncope—Epirubicin—peripheral nervous system neoplasm	0.00107	0.00108	CcSEcCtD
Rimantadine—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.00105	0.00107	CcSEcCtD
Rimantadine—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.00104	0.00106	CcSEcCtD
Rimantadine—Cough—Epirubicin—peripheral nervous system neoplasm	0.00104	0.00105	CcSEcCtD
Rimantadine—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.00103	0.00105	CcSEcCtD
Rimantadine—Nausea—Etoposide—peripheral nervous system neoplasm	0.00103	0.00104	CcSEcCtD
Rimantadine—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.00103	0.00104	CcSEcCtD
Rimantadine—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.00101	0.00103	CcSEcCtD
Rimantadine—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.00101	0.00102	CcSEcCtD
Rimantadine—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.00099	0.001	CcSEcCtD
Rimantadine—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000986	0.001	CcSEcCtD
Rimantadine—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000978	0.000993	CcSEcCtD
Rimantadine—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000972	0.000987	CcSEcCtD
Rimantadine—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000967	0.000982	CcSEcCtD
Rimantadine—Cough—Doxorubicin—peripheral nervous system neoplasm	0.00096	0.000974	CcSEcCtD
Rimantadine—Shock—Epirubicin—peripheral nervous system neoplasm	0.000954	0.000969	CcSEcCtD
Rimantadine—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000953	0.000968	CcSEcCtD
Rimantadine—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.00095	0.000964	CcSEcCtD
Rimantadine—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000947	0.000961	CcSEcCtD
Rimantadine—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000938	0.000952	CcSEcCtD
Rimantadine—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000933	0.000947	CcSEcCtD
Rimantadine—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000925	0.000939	CcSEcCtD
Rimantadine—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000916	0.00093	CcSEcCtD
Rimantadine—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000905	0.000919	CcSEcCtD
Rimantadine—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000883	0.000897	CcSEcCtD
Rimantadine—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000877	0.000891	CcSEcCtD
Rimantadine—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000876	0.00089	CcSEcCtD
Rimantadine—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000868	0.000881	CcSEcCtD
Rimantadine—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000865	0.000878	CcSEcCtD
Rimantadine—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000862	0.000876	CcSEcCtD
Rimantadine—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000856	0.000869	CcSEcCtD
Rimantadine—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000854	0.000867	CcSEcCtD
Rimantadine—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000843	0.000856	CcSEcCtD
Rimantadine—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000837	0.00085	CcSEcCtD
Rimantadine—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000836	0.000849	CcSEcCtD
Rimantadine—Constipation—Epirubicin—peripheral nervous system neoplasm	0.00083	0.000842	CcSEcCtD
Rimantadine—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000812	0.000824	CcSEcCtD
Rimantadine—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.0008	0.000813	CcSEcCtD
Rimantadine—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000799	0.000812	CcSEcCtD
Rimantadine—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000798	0.00081	CcSEcCtD
Rimantadine—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000793	0.000805	CcSEcCtD
Rimantadine—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.00079	0.000802	CcSEcCtD
Rimantadine—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.00078	0.000792	CcSEcCtD
Rimantadine—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000775	0.000787	CcSEcCtD
Rimantadine—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000774	0.000786	CcSEcCtD
Rimantadine—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000768	0.000779	CcSEcCtD
Rimantadine—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000767	0.000779	CcSEcCtD
Rimantadine—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.00074	0.000751	CcSEcCtD
Rimantadine—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000734	0.000745	CcSEcCtD
Rimantadine—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.00071	0.00072	CcSEcCtD
Rimantadine—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000696	0.000707	CcSEcCtD
Rimantadine—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000664	0.000674	CcSEcCtD
Rimantadine—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000644	0.000654	CcSEcCtD
Rimantadine—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000641	0.000651	CcSEcCtD
Rimantadine—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000617	0.000626	CcSEcCtD
Rimantadine—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000614	0.000624	CcSEcCtD
Rimantadine—Rash—Epirubicin—peripheral nervous system neoplasm	0.000612	0.000621	CcSEcCtD
Rimantadine—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000611	0.00062	CcSEcCtD
Rimantadine—Headache—Epirubicin—peripheral nervous system neoplasm	0.000608	0.000617	CcSEcCtD
Rimantadine—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000594	0.000603	CcSEcCtD
Rimantadine—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000576	0.000585	CcSEcCtD
Rimantadine—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000571	0.000579	CcSEcCtD
Rimantadine—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000566	0.000575	CcSEcCtD
Rimantadine—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000565	0.000574	CcSEcCtD
Rimantadine—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000562	0.000571	CcSEcCtD
Rimantadine—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000533	0.000541	CcSEcCtD
